Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 183Mechanical Circulatory Support DevicesPharmaceutical studies and practicesAntibiotics Pharmacokinetics and Efficacy

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Pharmacokinetic Changes During Extracorporeal Membrane Oxygenation: Implications for Drug Therapy of Neonates

Buck, Marcia L·2003·Clinical Pharmacokinetics
DOI 10.2165/00003088-200342050-00001
Open this paper in CoChat — free account

Abstract

Extracorporeal membrane oxygenation (ECMO) is a prolonged form of cardiopulmonary bypass used to support patients with life-threatening respiratory or cardiac failure. In neonates, ECMO is used for a variety of indications, including sepsis and pulmonary diseases such as meconium aspiration syndrome, persistent pulmonary hypertension or congenital diaphragmatic hernia. In recent years, ECMO has been increasingly used after surgery to correct congenital cardiac defects. Despite the need for numerous drugs to maintain the ECMO circuit and treat the patient's underlying illness, relatively little is known of the disposition of drugs in this patient population. To date, the largest number of pharmacokinetic studies have been conducted with gentamicin and vancomycin. Both drugs have been found to have an increased volume of distribution, probably as a result of the addition of a large exogenous blood volume for circuit priming. Elimination half-lives for both drugs are prolonged during ECMO, with several studies demonstrating a return to expected values after decannulation. The reason for this prolonged elimination is probably multifactorial, with a reduction in renal function as the primary determinant. This same pattern of an increased volume of distribution and prolonged elimination has been found for several other drugs, including tobramycin, bumetanide and ranitidine. Other factors that affect drug disposition during ECMO include loss of the drug from adhesion to the circuit components and loss in the circulating blood volume during changes in the equipment. The benzodiazepines and propofol are largely sequestered within the circuit. Serum concentrations of heparin, morphine, fentanyl, furosemide, phenytoin and phenobarbital are also reduced by these mechanisms. The addition of haemofiltration or dialysis in up to a quarter of ECMO patients further complicates the determination of population pharmacokinetic parameters. The literature published to date on the pharmacokinetic changes associated with ECMO provide preliminary support for dosage adjustment; however, more research is needed to identify optimal administration strategies for this patient population.

Overview

Integrity signals

Registry

Crossref · 10.2165/00003088-200342050-00001

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Research works printed but not linked: 6

  1. Buck, 1995, Pharmacotherapy, 15, 384
  2. Munzenberger, 1991, ASAIO Trans, 37, 16, 10.1097/00002480-199101000-00006 · DOI
  3. Hoie, 1990, Clin Pharm, 9, 711
  4. Roy, 1995, Pediatrics, 95, 573
  5. Hoie, 1993, Am J Hosp Pharm, 50, 1902
  6. Marx, 1991, Pharmacotherapy, 11, 270

Cited by

Items 101–183 of 183

Related

See all

Metadata

Authors
Buck, M. L.
Affiliations
University of Virginia Health System (US)
Corresponding author
Buck, Marcia L
ORCID
Buck, Marcia L
Venue
Clinical Pharmacokinetics
Publisher
Springer Science and Business Media LLC
Published
2003
Volume
42
Issue
5
Pages
403-417
ISSN
0312-5963 (ISSN-L)
DOI
10.2165/00003088-200342050-00001
OpenAlex
W145838624
Cited by
179
References
47
Citations by year
2026: 3 · 2025: 6 · 2024: 6 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 10 · 2017: 19 · 2016: 14 · 2015: 3 · 2014: 9 · 2013: 7 · 2012: 18
FWCI
0.54
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Pharmacokinetics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Mechanical Circulatory Support Devices
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords
extracorporeal membrane oxygenation, pharmacokinetics, drug disposition, neonates, gentamicin, vancomycin, volume of distribution, elimination half-life, renal function, hemofiltration, dialysis, dose adjustment, congenital heart disease, sepsis, meconium aspiration syndrome, persistent pulmonary hypertension, congenital diaphragmatic hernia
MeSH terms
Animals, Pharmaceutical Preparations, Humans, Infant, Newborn, Pharmacokinetics, Extracorporeal Membrane Oxygenation, Models, Animal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.